1 / 31

Compact

Compact. CNS. Baroreflex. I-1. α 2. Vagus Nerve. Preload. Afterload. α 1. GI Vasculature. B1. ANP. ADH. B2. Renin. NO. M2 -. B1 +. Aldosterone. Conductivity. Na↑ HCO3↓. Na↑ K↓. ATII. Na Cl↑ + K↓. PG. Na↑ Ca↑ Mg↑ K↑. Na↑. CNS. Baroreflex. Preload.

jihan
Download Presentation

Compact

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Compact CNS Baroreflex I-1 α 2 Vagus Nerve Preload Afterload α 1 GI Vasculature B1 ANP ADH B2 Renin NO M2 - B1 + Aldosterone Conductivity Na↑ HCO3↓ Na↑ K↓ ATII Na Cl↑ + K↓ PG Na↑ Ca↑ Mg↑ K↑ Na↑

  2. CNS Baroreflex Preload Afterload I-1 α 2 Vagus Nerve α 1 GI Vasculature Expanded B1 ANP B2 NO ADH Renin M2 - B1 + Aldosterone Conductivity Na↑ HCO3↓ Na↑ K↓ ATII Na Cl↑ + K↓ PG Na↑ Ca↑ Mg↑ K↑ Na↑

  3. Cardiac Pharmacology Ted Williams Pharm D Candidate OSU/OHSU College of Pharmacy

  4. The big, scary picture

  5. Breaking it Down • Direct Cardiac Agents • Peripheral Vascular Agents • Renal Agents

  6. Reality Check • The pharmacology really isn’t that simple, but it is a helpful framework

  7. Direct Cardiac Agents • Beta Blockers (BB) • Non-Dihydropyridine Calcium Channel Blockers (CCB) • Digitalis Glycoside (De-GOX-in) • Aldosterone antagonists • Well explain why this is here later

  8. Peripheral Vascular Agents • Nitrates • Dihydropyridine CCB • Phosphodiesterase Inhibitors • Quinazolines (Alpha 1 Antagonists) • Hydralazine • Celiprolol • Phentolamine

  9. Renal Agents • ACE Inhibitors • Angiotensin 2 Inhibitors • Diuretics • Carbonic Anhydrase Inhibitors • Loop • Thiazide Diuretics • Aldosterone Antagonists • Potassium Sparing Diuretics

  10. Mixed Bag • Selective I-1 Imidazoline Receptor Agonists

  11. Direct Cardiac Agents – BB • Selectivity • Beta 1 Selective • Beta 1/2 Non-Selective • Alpha 1, Beta 1/2 Non-Selective • Alpha 2, Beta 1/2 Non-Selective • Intrinsic Sympathomimetic Activity (ISA) • ISA • No long term mortality benefit Post MI • Non-ISA do have benefit post MI • Non-ISA

  12. Targets of Beta Blockers CNS Baroreflex I-1 α 2 Vagus Nerve Preload Afterload α 1 GI Vasculature B1 ANP ADH NO B2 Renin M2 - Aldosterone B1 + Conductivity Na↑ HCO3↓ Na↑ K↓ ATII Na Cl↑ + K↓ PG Na↑ Ca↑ Mg↑ K↑ Na↑

  13. Targets of Beta Blockers • Beta 1 blockade • “Cardioselective” • Inhibits sympathetic contractility, inotropy, and conductivity of the heart • Inhibits sympathetic renin secretion in the kidneys • Best Tolerated Beta 1 Blockers • Atenolol • Acebutolol • Bisoprolol • Metoprolol

  14. Targets of Beta Blocker • Beta 2 blockade • Beta 2 receptors inhibit smooth muscle contractions in the lungs and GI tract • Beta 2 blockade is useful for restricting hepatic blood flow for patient with Liver Cirrhosis, but generally not a therapeutic effect for CVD • Commonly Used Beta 2 Blockers • Propranolol • Nadolol

  15. Targets for Non-Dihydropyridine Calcium

  16. Targets of Digoxin

  17. Targets of Aldosterone Antagonists

  18. Targets of Aldosterone Antagonists

  19. Peripheral Vascular Agents • Nitrates • Dihydropyridine CCB • Phosphodiesterase Inhibitors • Quinazolines (Alpha 1 Antagonists) • Hydralazine • Celiprolol • Phentolamine

  20. Targets of Nitrates

  21. Targets of Nitrates • Preferential vasodilation of veins • Decreases Preload • Decreases Afterload

  22. Targets of Dihydropyridine CCB

  23. Targets of Dihydropyridine CCB • Peripheral Vasodilation • State dependent binding to the Inactive State • Tissues more often in the inactive state have tissue selectivity • Targets vascular smooth muscle, generally arterial • Decreases afterload and increases stroke volume • Reduces blood pressure

  24. Targets of Phosphodiesterase Inhibitors

  25. Targets of Phosphodiesterase inhibitors • Promotes vasodilation by increases cGMP • Decreases Afterload • Good for Heart Failure • Secondary decrease in preload • Reflex tachycardia via the baroreflex • No so good for heart failure patients • Resistance develops rapidly with continuous use, limiting therapeutic uses to acute decompensated heart failure

  26. Hydralazine • Mechanism not well understood

  27. Celiprolol

  28. Phentolamine

  29. Targets for Alpha Blockers CNS Baroreflex Preload Afterload I-1 α 2 Vagus Nerve α 1 GI Vasculature B1 ANP ADH NO B2 Renin M2 - Aldosterone B1 + Conductivity Na↑ HCO3↓ Na↑ K↓ ATII Na Cl↑ + K↓ PG Na↑ Ca↑ Mg↑ K↑ Na↑

  30. Targets for Alpha Blockers • Alpha 1 Blockade • Peripheral Vasodilation by inhibition of Gq Signaling pathway • Carvedilol (alpha-1, beta 1/2) • Labetalol (alpha-1, beta 1/2) • Quinazolines • (Prazosin, Tamsulosin, Terasozin, Alfazosin) • Alpha 2 Blockade • CNS Inhibition the inhibition of the baroreflex • Peripheral inhibition of the negative feedback on vagal cardiac stimulation • Celiprolol (alpha-2, beta-1 blockade)

More Related